• Home
  • Taxotere Lawsuits

Taxotere Permanent Hair Loss Lawsuits

This Alert Affects:

Anyone who received chemotherapy with Taxotere and suffered permanent hair loss (alopecia).

What's Going On?
Patients are filing lawsuits saying that they weren't fully warned about the risk of alopecia and have suffered serious psychological damage after permanently losing their hair.
Who Are the Lawsuits Being Filed Against?
The manufacturer of the drug, Sanofi S.A.
What's the Purpose of the Lawsuits?
To help patients recover money for their mental suffering, therapy bills and inability to work.

Across the country, women who received Taxotere during chemotherapy are filing lawsuits saying that they permanently lost their hair because of the drug. They’re seeking compensation from the manufacturer for mental suffering, therapy bills and their inability to return to work because of the psychological damage they suffered.

If you’re interested in learning more about filing a lawsuit against the maker of Taxotere, contact ClassAction.org today. We work with lawyers across the country and may be able to put you in touch with someone who can help. There is no charge for our services and there is never any cost for talking to a lawyer.

Why Were Lawsuits Filed over Taxotere?

The lawsuits were filed to help patients recover money from the drug’s manufacturer for the harm they suffered after losing their hair. The suits claim that the maker of the drug, Sanofi:

  • Gave doctors illegal kickbacks for prescribing Taxotere for off-label uses
  • Didn’t properly warn patients about the risk of permanent, chemotherapy-induced alopecia (hair loss)
  • Exposed patients to a drug that was more toxic than other alternatives  
  • Trained their sales team to misrepresent the safety and effectiveness of the drug for off-label use
  • Knew or should have known that the risk of permanent hair loss was much greater with Taxotere than competitors’ drugs  

As a result, the suits claim, Sanofi is responsible for providing compensation to women who suffered permanent hair loss as a result of receiving the drug.  

Suit: Taxotere Promoted for Off-Label Uses Not Approved by FDA

Taxotere was approved by the FDA in May 1996. The drug was indicated for the treatment of patients with advanced or metastatic breast cancer after chemotherapy with another drug failed. The suits claim, however, that Sanofi allegedly promoted the drug for use in patients with early-stage breast cancer.

The suits also claim that the company marketed the drug as more effective than competitors’ drugs – even though studies showed that Taxotere didn’t offer any increased benefits. In fact, research published in the New England Journal of Medicine in 2008 found that competitor drug Taxol was actually more effective than Taxotere in certain patients.

In 2009, the FDA sent Sanofi a warning letter in 2009 accusing the company of making false and misleading statements about the efficacy of its drug.

How Lawsuits Can Help

Lawsuits can help women recover compensation for harm they suffered after losing their hair. These damages can include:

  • Mental suffering (anxiety, depression, etc.)
  • Medical expenses, including counseling and therapy
  • Lost wages or inability to work due to psychological damage
  • Disfigurement
  • Loss of quality of life

The lawsuits can also help ensure that Sanofi – and other drug makers – market their products for FDA-approved uses only.

What You Can Do If You Had Permanent Hair Loss from Taxotere

If you or loved one received chemotherapy with Taxotere and suffered permanent hair loss, contact ClassAction.org today. We can send your information to one of the attorneys we work with. He or she may then reach out to you directly, either via phone or e-mail. The attorney can explain more about your rights and what it takes to file a lawsuit. There’s no cost to contact us or to talk to the attorneys we work with. Plus, these are the only people who will ever receive your information. 

Before commenting, please review our comment policy.

Get in Touch

By submitting this form I agree to the Terms of Use

Stop H.R. 985

A reckless new bill represents an unprecedented threat to consumer rights, essentially gutting class action and mass tort litigation. Congress has tried to ram it through without us noticing. Read more about the implications of this bill, and contact your members of Congress to protect your rights.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, programmers and writers) with years of experience in the legal industry. We work closely with class action and mass tort attorneys across the country and help with investigations into corporate wrongdoing.

Sign Up For Our Newsletter

New cases and investigations, settlement deadlines, and news - straight to your inbox.

Case Resources

Spann v. Sanofi S.A., et al.
Read a lawsuit filed against Sanofi that alleges Taxotere puts women at risk for permanent hair loss – also known as alopecia.